Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
This is not equivalent to the FDA granting approval as a therapeutic drug, and it carries no standing under UK or EU medicines law
Supporting this, in a phase 2a trial in people with MASLD, the dual GLP-1/GCG agonist efinopegdutide (10 mg) reduced liver fat by 72.7%, compared to 42.3% with semaglutide (1 mg) despite similar WLindicating potential weight-independent effects of GCG on hepatic steatosis [40]
At this anchor dose, the per-injection payload is: 3 mg GHK-Cu 0.6 mg BPC-157 0.6 mg TB-4 20-unit draw: 3.33 mL BAC water produces 15 mg GHK-Cu/mL
They are intramuscular shots given daily initially and then monthly
US$ 24.14
US$ 21.46
US$ 27.98
